首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Emergence of Colistin Resistance in Enterobacteriaceae after the Introduction of Selective Digestive Tract Decontamination in an Intensive Care Unit
【2h】

Emergence of Colistin Resistance in Enterobacteriaceae after the Introduction of Selective Digestive Tract Decontamination in an Intensive Care Unit

机译:重症监护病房引入选择性消化道去污后肠杆菌科菌对Colistin的耐药性出现

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Selective decontamination of the digestive tract (SDD) selectively eradicates aerobic Gram-negative bacteria (AGNB) by the enteral administration of oral nonabsorbable antimicrobial agents, i.e., colistin and tobramycin. We retrospectively investigated the impact of SDD, applied for 5 years as part of an infection control program for the control of an outbreak with extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae in an intensive care unit (ICU), on resistance among AGNB. Colistin MICs were determined on stored ESBL-producing K. pneumoniae isolates using the Etest. The occurrence of both tobramycin resistance among pathogens intrinsically resistant to colistin (CIR) and bacteremia caused by ESBL-producing K. pneumoniae and CIR were investigated. Of the 134 retested ESBL-producing K. pneumoniae isolates, 28 were isolated before SDD was started, and all had MICs of <1.5 mg/liter. For the remaining 106 isolated after starting SDD, MICs ranged between 0.5 and 24 mg/liter. Tobramycin-resistant CIR isolates were found sporadically before the introduction of SDD, but their prevalence increased immediately afterward. Segmented regression analysis showed a highly significant relationship between SDD and resistance to tobramycin. Five patients were identified with bacteremia caused by ESBL-producing K. pneumoniae before SDD and 9 patients thereafter. No bacteremia caused by CIR was found before SDD, but its occurrence increased to 26 after the introduction of SDD. In conclusion, colistin resistance among ESBL-producing K. pneumoniae isolates emerged rapidly after SDD. In addition, both the occurrence and the proportion of tobramycin resistance among CIR increased under the use of SDD. SDD should not be applied in outbreak settings when resistant bacteria are prevalent.
机译:消化道(SDD)的选择性净化通过口服不可吸收的抗菌剂,如大肠菌素和妥布霉素的肠内给药,有选择地根除好氧革兰氏阴性菌(AGNB)。我们回顾性研究了作为感染控制计划一部分,用于控制重症监护病房(ICU)中产生超广谱β-内酰胺酶(ESBL)的肺炎克雷伯菌肺炎爆发的SDD持续5年的影响在AGNB中。使用Etest在储存的产生ESBL的肺炎克雷伯菌分离株中测定了共Listin MIC。研究了由产生ESBL的肺炎克雷伯菌和CIR引起的对大肠菌素(CIR)固有耐药性和菌血症的致病菌中对妥布霉素耐药性的发生。在134个经过重新测试的产生ESBL的肺炎克雷伯菌分离物中,有28个在开始SDD之前就已分离,并且所有MIC均<1.5 mg / L。对于开始SDD后分离出的其余106个,MIC范围为0.5至24 mg / L。在引入SDD之前偶发地发现耐妥布霉素的CIR分离株,但此后其流行率立即升高。分段回归分析显示,SDD和对妥布霉素的抗性之间存在高度显着的关系。在SDD之前,有5例患者被鉴定为由产生ESBL的肺炎克雷伯菌引起的菌血症,其后为9例。在SDD之前未发现CIR引起的菌血症,但在SDD引入后其发生率增加到26。总之,在SDD后,产生ESBL的肺炎克雷伯菌分离株中的粘菌素抗性迅速出现。另外,在使用SDD的情况下,CIR中妥布霉素耐药性的发生和比例均增加。当抗药性细菌普遍存在时,不应在爆发环境中使用SDD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号